NeuroSense TherapeuticsNRSN
那斯達克 · USD
0.97
-0.05
(-5.19%)
收盤 01/22 04:59 (UTC+8)
01/22 04:59 (UTC+8)
NeuroSense TherapeuticsNRSN
0.97
-0.05
(-5.19%)
財務數據
損益表
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q2 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
營業費用 | - | 1,771 | 2,107 | 3,030 | 2,994 | 3,287 | 2,897 | 3,477 | 2,991 | 3,379 |
研發費用 | - | 1,086 | 1,161 | 1,569 | 1,882 | 1,958 | 1,625 | 1,907 | 1,852 | 1,544 |
推銷及管理費用 | - | 685 | 946 | 1,461 | 1,112 | 1,329 | 1,272 | 1,570 | 1,139 | 1,835 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | - | -1,771 | -2,107 | -3,030 | -2,994 | -3,287 | -2,897 | -3,477 | -2,991 | -3,379 |
其他收入及費用 | - | - | - | - | - | - | - | - | - | - |
利息費用 | - | - | - | -2,173 | 2,410 | -2,197 | 2,202 | -304 | 310 | -53 |
稅前純益 | - | -1,801 | -2,148 | -857 | -5,404 | -2,950 | 784 | -5,225 | -2,924 | -3,150 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | - | -1,801 | -2,148 | -857 | -5,404 | -2,950 | 784 | -5,225 | -2,924 | -3,150 |
基本每股稅後盈餘(元) | - | - | - | - | -0.35 | - | - | -0.44 | -0.25 | -0.27 |
稀釋每股稅後盈餘(元) | - | - | - | - | -0.35 | - | - | -0.44 | -0.25 | -0.27 |
基本平均股數(千股) | - | - | - | - | 15405.00 | - | - | 15461.00 | 11785.00 | 11835.00 |
稀釋平均股數(千股) | - | - | - | - | 15405.00 | - | - | 15461.00 | 11785.00 | 11835.00 |
還原基本每股稅後盈餘(元) | - | - | - | - | -0.35 | - | - | -0.44 | -0.25 | -0.27 |
還原稀釋每股稅後盈餘(元) | - | - | - | - | -0.35 | - | - | -0.44 | -0.25 | -0.27 |
還原基本平均股數(千股) | - | - | - | - | 15,405 | - | - | 15,461 | 11,785 | 11,835 |
還原稀釋平均股數(千股) | - | - | - | - | 15,405 | - | - | 15,461 | 11,785 | 11,835 |
EBITDA(千元) | 0 | -1,801 | -2,148 | -3,030 | -2,994 | -5,147 | 2,986 | -5,529 | -2,614 | -3,203 |